Bone Turnover Marker Profiling and Fracture Risk in Older Women: Fracture Risk from Age 75 to 90

[1]  J. Kanis,et al.  SCOPE 2021: a new scorecard for osteoporosis in Europe , 2021, Archives of Osteoporosis.

[2]  C. Libanati,et al.  History of Previous Fracture and Imminent Fracture Risk in Swedish Women Aged 55 to 90 Years Presenting With a Fragility Fracture , 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  D. Siscovick,et al.  Biochemical markers of bone turnover and risk of incident hip fracture in older women: the Cardiovascular Health Study , 2019, Osteoporosis International.

[4]  A. LaCroix,et al.  Bone Turnover Markers Are Not Associated With Hip Fracture Risk: A Case‐Control Study in the Women's Health Initiative , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  R. Eastell,et al.  Use of bone turnover markers in postmenopausal osteoporosis. , 2017, The lancet. Diabetes & endocrinology.

[6]  R. Eastell,et al.  Bone Turnover Markers: Use in Fracture Prediction. , 2017, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[7]  C. Roux,et al.  Imminent fracture risk , 2017, Osteoporosis International.

[8]  Naylor,et al.  Bone turnover markers : are they clinically useful ? , 2017 .

[9]  S. Norgren,et al.  Mortality Is Not Increased in Recombinant Human Growth Hormone-treated Patients When Adjusting for Birth Characteristics. , 2016, The Journal of clinical endocrinology and metabolism.

[10]  S. Vasikaran,et al.  The use of biochemical markers of bone turnover in the clinical management of primary and secondary osteoporosis , 2016, Endocrine.

[11]  R. Shigdel,et al.  Bone turnover markers are associated with higher cortical porosity, thinner cortices, and larger size of the proximal femur and non-vertebral fractures. , 2015, Bone.

[12]  H. Koistinen,et al.  The effects of acute hyperinsulinemia on bone metabolism , 2015, Endocrine connections.

[13]  J. Beilby,et al.  Reference intervals for bone turnover markers and their association with incident hip fractures in older men: the Health in Men study. , 2015, The Journal of clinical endocrinology and metabolism.

[14]  H. Luthman,et al.  C-reactive protein, bone loss, fracture, and mortality in elderly women: a longitudinal study in the OPRA cohort , 2015, Osteoporosis International.

[15]  M. Ridderstråle,et al.  Vitamin D insufficiency over 5 years is associated with increased fracture risk—an observational cohort study of elderly women , 2014, Osteoporosis International.

[16]  P. Gerdhem,et al.  External validity of a population-based study on osteoporosis and fracture , 2014, Acta orthopaedica.

[17]  C. Cooper,et al.  A Meta-Analysis of Reference Markers of Bone Turnover for Prediction of Fracture , 2014, Calcified Tissue International.

[18]  Noriko Yoshimura,et al.  A Meta‐Analysis of the Association of Fracture Risk and Body Mass Index in Women , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  C. Colón-Emeric.  Recent Advances: Osteoporosis in the “Oldest Old” , 2013, Current Osteoporosis Reports.

[20]  E. Cavalier,et al.  IDS iSYS automated intact procollagen-1-N-terminus pro-peptide assay: method evaluation and reference intervals in adults and children , 2013, Clinical chemistry and laboratory medicine.

[21]  P. Gerdhem,et al.  Degenerative changes at the lumbar spine—implications for bone mineral density measurement in elderly women , 2013, Osteoporosis International.

[22]  M. Iki,et al.  Biochemical markers for bone turnover predict risk of vertebral fractures in postmenopausal women over 10 years: the Japanese Population-based Osteoporosis (JPOS) Cohort Study , 2013, Osteoporosis International.

[23]  H. Bischoff-Ferrari.  The Role of Falls in Fracture Prediction , 2011, Current osteoporosis reports.

[24]  C. Cooper,et al.  International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine Position on bone marker standards in osteoporosis , 2011, Clinical chemistry and laboratory medicine.

[25]  B. Kestenbaum,et al.  Mineral metabolism markers and the long-term risk of hip fracture: the cardiovascular health study. , 2011, The Journal of clinical endocrinology and metabolism.

[26]  C. Cooper,et al.  Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards , 2011, Osteoporosis International.

[27]  P. Gerdhem,et al.  Bone turnover markers and prediction of fracture: A prospective follow‐up study of 1040 elderly women for a mean of 9 years , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  J. Cauley,et al.  Biochemical Markers of Bone Turnover, Hip Bone Loss, and Fracture in Older Men: The MrOS Study , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  P. Gerdhem,et al.  Serial assessment of serum bone metabolism markers identifies women with the highest rate of bone loss and osteoporosis risk. , 2008, The Journal of clinical endocrinology and metabolism.

[30]  P. Delmas,et al.  High bone turnover is associated with accelerated bone loss but not with increased fracture risk in men aged 50 and over: the prospective MINOS study , 2007, Annals of the rheumatic diseases.

[31]  O. Johnell,et al.  FRAX™ and the assessment of fracture probability in men and women from the UK , 2008, Osteoporosis International.

[32]  P. Gerdhem,et al.  Rates of fracture in participants and non-participants in the Osteoporosis Prospective Risk Assessment study. , 2007, The Journal of bone and joint surgery. British volume.

[33]  G. Riedmüller,et al.  Hip and nonvertebral fracture prediction in nursing home patients: role of bone ultrasound and bone marker measurements. , 2007, The Journal of clinical endocrinology and metabolism.

[34]  P. Kannus,et al.  Urinary osteocalcin is a useful marker for monitoring the effect of alendronate therapy. , 2005, Clinical chemistry.

[35]  P. Gerdhem,et al.  Biochemical markers of bone turnover are influenced by recently sustained fracture. , 2005, Bone.

[36]  P. Gerdhem,et al.  Urinary osteocalcin as a marker of bone metabolism. , 2005, Clinical chemistry.

[37]  J. Eisman,et al.  Bone Resorption and Osteoporotic Fractures in Elderly Men: The Dubbo Osteoporosis Epidemiology Study , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[38]  Anders Isaksson,et al.  Biochemical Markers of Bone Metabolism and Prediction of Fracture in Elderly Women , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[39]  S. Käkönen,et al.  Fracture-induced changes in bone turnover: a potential confounder in the use of biochemical markers in osteoporosis , 2004, Journal of Bone and Mineral Metabolism.

[40]  P. Delmas,et al.  Biochemical Markers of Bone Turnover, Endogenous Hormones and the Risk of Fractures in Postmenopausal Women: The OFELY Study , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[41]  P. Delmas,et al.  Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: the EPIDOS study. , 2000, Bone.

[42]  M. Karp,et al.  Development and evaluation of three immunofluorometric assays that measure different forms of osteocalcin in serum. , 2000, Clinical chemistry.

[43]  C Marcelli,et al.  Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[44]  O. Johnell,et al.  Remembering fractures: fracture registration and proband recall in southern Sweden. , 1994, Journal of epidemiology and community health.

[45]  N. Breslow,et al.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.